Pinatuzumab vedotin explained

Pinatuzumab vedotin (INN;[1] development codes DCDT2980S and FCU2703) is a monoclonal antibody designed for the treatment of B-cell malignancies.[2]

This drug was developed by Genentech/Roche.

References

  1. . International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 108 . WHO Drug Information . 26 . 4 . 2012 .
  2. http://www.ama-assn.org/resources/doc/usan/x-pub/pinatuzumab-vedotin.pdf Statement On A Nonproprietary Name Adopted By The USAN Council - Pinatuzumab Vedotin

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Pinatuzumab vedotin".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2025, A B Cryer, All Rights Reserved. Cookie policy.